Essential Program Management Considerations for Biopharma With Jamie Martin

April 9, 2023

In this episode of Evaluating Biopharma, host Ben Locwin and Jamie Martin, PMP, senior consultant at Black Diamond Networks, discuss the tips and tricks of successful program management. Martin shares his mental checklist of must-haves to ensure a successful start, techniques on what to do when things fall off-track, and the keys to continuous success as the program is running. He also provides advice for listeners who may have newer programs or are new to program management, as well as the “best-in-class" tidbits they can immediately use.

GUEST BIO

Jamie Martin, PMP, senior consultant at Black Diamond Networks, is a process and program management professional with 20 years of experience in the biotechnology industry. He has extensive experience in biopharmaceutical process tech transfer from scale up and development through process improvement, qualification and regulatory submission & approval. He is an accomplished program manager and leader in medical device and combination device space including product development, design verification & validation, quality systems implementation and regulatory submissions & approval. To his credit he has three biopharmaceutical process transfers resulting in successful process qualification and regulatory clearance and six Class II and III medical devices taken from early phase product development through regulatory clearance and commercial launch. He’s implemented quality management systems and system improvements across multiple biotech sector.

MODERATOR BIO

Ben Locwin, vice president of project solutions, Black Diamond Networks
Ben Locwin is a healthcare executive and industry expert. His work has involved bringing new and innovative medical treatments (drug therapies, vaccines and medical devices) to patient populations with unmet needs across a variety of indications and health conditions. He has also worked with investors on the ‘next big things’ in the industry. He has been featured in The Wall Street Journal, Forbes, USA Today, The Associated Press, Axios, NPR, and other top-tier media.